Sign Up
OverviewAPI
Genmab A/S experiences internal transaction scrutiny concerning shares and linked securities by managerial employees and closely associated individuals. The international biotech company, Genmab, is dedicated to advancing antibody therapeutics to enhance patient well-being and has set ambitious goals to revolutionize patient outcomes with groundbreaking antibody treatments by 2030.

Ask a question